Personalized and Precision Medicine Journal
Where Innovations Meets Personalized and Precision Medicine

Exploring the Antidepressant effect of Aqueous-Alcoholic extract of purslane plant (Portulaca oleracea) on Asthma-induced depression in Mice:Insights from Open Field and Forced Swimming Tests

Document Type : Original Article

Authors

Najmeh Khatun Dehnavi 1
Ali Neamati 2

1 Department of Biology, IAUM, Islamic Azad University, Mashhad, Iran.

2 Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran

https://doi.org/10.22034/pmj.2025.2048504.1048
Abstract
Background and purpose: Asthma is one of the most common chronic diseases in which inflammation plays an essential role in its pathophysiology. One of the secondary effects of asthma is depression, which is probably due to overlapping pathogenic mechanisms. One of the important mechanisms in the treatment of depression and asthma is to pay attention to removing inflammation and reducing oxidative stress. Purslane exerts its anti-inflammatory and antioxidant effects through NFqB and NOS pathways. This study aims to investigate the effect of the aqueous-alcoholic extract of the purslane plant on depression caused by experimental asthma using an Open Field Test and Forced Swimming Test in small laboratory mice.
Materials and methods: To investigate the aqueous-alcoholic extract of the purslane plant on depression caused by experimental asthma, 40 Syrian NMRI male mice were divided into 4 groups: control, asthmatic, and asthmatic receiving the extract at a dose of 50 mg/kg and 100 mg/kg. Syrian mice were injected and inhaled ovalbumin to develop asthma, and the control group received PBS solution in the same way. The treated groups received the extract at the same time as asthma induction.
Results: The results show that depression symptoms increased significantly after asthma induction. These symptoms were significantly reduced after the administration of purslane extract in a dose-dependent manner. The results indicated a significant increase in depression in the asthmatic group samples compared to the control group and also a significant decrease in depression in the groups treated with purslane extract compared to the asthmatic group.

Keywords

Asthma
Depression
Inflammation
Oxidative stress
Purslane

Subjects

1.Horak F, Doberer D, Eber E, Horak  E, Pohl  W, Riedler J et al. Diagnosis and management of asthma–Statement on the 2015 GINA Guidelines. Wiener klinische Wochenschrift 2016; 128(15-16): 541-554.
2.Mauad T, Bel  EH, Sterk  PJ. Asthma therapy and airway remodeling. Journal of allergy and clinical immunology 2007; 120(5):997-1009.‏
3.Pawankar R, Canonica  GW, Holgate ST,  Lockey  RF, Blaiss M. World Allergy Organization (WAO) white book on allergy. Wisconsin: World Allergy Organisation 2011.
4.Heidarnia  MA, Entezari  A, Moein  M,  Mehrabi Y, Pourpak Z.  Prevalence of asthma symptom in Iran: a meta-analysis. Research in Medicine 2007; 31(3): 217-225.
5.Kim HY, DeKruyff RH, Umetsu DT. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nature immunology 2010; 11(7): 577.‏
6.Martinez FD. Genes, environments, development and asthma: a reappraisal. European Respiratory Journal 2007; 29(1): 179-184.
7.Miller RL, Ho SM. Environmental epigenetics and asthma: current concepts and call for studies. American journal of respiratory and critical care medicine 2008; 177(6):567-573.
8.Goodwin RD, Jacobi F, Thefeld W. Mental disorders and asthma in the community. Archives of general psychiatry 2003; 60(11): 1125-1130.
9.Opolski M, Wilson I. Asthma and depression: a pragmatic review of the literature and recommendations for future research. Clinical Practice and Epidemiology in Mental Health 2005; 1(1): 18.
10.Chun TH, Weitzen SH, Fritz GK.. The asthma/mental health nexus in a population-based sample of the United States. CHEST Journal 2008; 134(6):1176-1182.
11.Dunbar  F. Mind and Body: Psychosomatic Medicine 1948.
12.Goldney R, Ruffin R, Fisher L, Wilson D. Asthma symptoms associated with depression and lower quality of life: a population survey 2003.
13.Zielinski TA, Brown ES, Nejte, VA, Khan DA, Moore JJ, Rush AJ. Depression in asthma: prevalence and clinical implications. Primary care companion to the Journal of clinical psychiatry 2000;2(5): 153.
14.Valenç AM, Falcão R, Freire RC, Nascimento I, Nascentes R, Zin WA et al. The relationship between the severity of asthma and comorbidites with anxiety and depressive disorders. Revista Brasileira de Psiquiatria 2006; 28(3):206-208.
15.Sagols E, Priymenk N. Oxidative stress in dog with heart failure: the role of dietary fatty acids and antioxidants. Veterinary medicine international  2011.
16.Haneklaus  M, O’neill  LA.  NLRP3 at the interface of metabolism and inflammation. Immunological reviews 2015; 265(1): 53-62.
17.Baines KJ, Backer V, Gibson PG, Powel H, Porsbjerg CM. Impaired lung function is associated with systemic inflammation and macrophage activation. European Respiratory Journal 2015;45(2): 557-559. 
18.Morjaria JB, Babu KS, Vijayanand P, Chauhan AJ, Davies DE, Holgate ST. Sputum IL-6 concentrations in severe asthma and its relationship with FEV1. Thorax, thx 2010.
19.Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. CHEST Journal 2012; 142(1): 86-93.
20.Liu L, Howe P, Zhou YF, Xu ZQ, Hocart C, Zhang R. Fatty acids and β-carotene in Australian purslane (Portulaca oleracea) varieties. Journal of chromatography a 2000; 893(1): 207-213.
21.Samy J, Sugumaran M, Lee KL. Herbs of Malaysia: an introduction to the medicinal, culinary, aromatic and cosmetic use of herbs. Times Editions. 2005.
22.Yan  J, Sun  LR, Zhou  ZY, Chen  YC, Zhang  WM, Dai  HF, Tan  JW. Homoisoflavonoids from the medicinal plant Portulaca oleracea. Phytochemistry 2012; 80: 37-41.
23. Okafor IA, Ayalokunrin MB, Orachu LA. A review on Portulaca oleracea (Purslane) plant–Its nature and biomedical benefits. Int J Biomed Res 2014 ; 5(2): 75-80.
24. Brian  R.Urban Edibles: Weeds 2012.
25. Jalali sf, baradaran m, mahdinezhad sm, roushan t. Effect of Coenzyme-Q10 in Congestive Heart Failure 2010.
26.Alam MA, Juraimi AS, Rafii MY, Abdul Hamid A, Aslani F, Hasan MM et al. Evaluation of antioxidant compounds, antioxidant activities, and mineral composition of 13 collected purslane (Portulaca oleracea L.) accessions. BioMed research international 2014.
27.Hongyan W, Songli W, Qunce H. Advance in the Research of Portulaca oleracea L. (Wild Vegetable) [J]. Chinese Agricultural Science Bulletin 2004; 2, 010.
28.Simopoulos AP, Tan DX, Manchester  LC, Reiter RJ. Purslane: a plant source of omega‐3 fatty acids and melatonin. Journal of pineal research 2005; 39(3): 331-332.
29.Keyhanmanesh R, Alipour MR, Ebrahimi H, Aslani MR. Effects of Diet-Induced Obesity on Tracheal Responsiveness to Methacholine, Tracheal Visfatin Level, and Lung Histological Changes in Ovalbumin-Sensitized Female Wistar Rats. Inflammation 2018; 41(3): 846-858.
30.Ahmadi  M, Rahbarghazi  R, Soltani S, Aslani MR, Keyhanmanesh  R. Contributory anti-inflammatory effects of mesenchymal stem cells, not conditioned media, on ovalbumin-induced asthmatic changes in male rats. Inflammation 2016; 39(6): 1960-1971.
31.Wang Z, Gu J, Wang X, Xie KL, Wan N, Liu D. Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK. Pharmacology Biochemistry and Behavior 2013; 112: 104-110.
32.MILADI GH, Rashidipour A, Ghorbani  R. Antinociceptive effects of the aqueous extracts of Portulaca oleracea seeds in mice 2005.
33.KHOSRAVI H, RAHNEMA M, ASLE RM. Anxiolytic and antidepressant effects of tarragon (Artemisia dracunculus L.) hydroalcoholic extract in male rats exposed to chronic restraint stress 2017. 
34.Hosseinzadeh  H, Sadeghnia  HR. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci 2005; 8(3): 394-399.‏
35.Jalali sf, baradaran  m,  mahdinezhad  sm, roushan  t. Effect of Coenzyme-Q10 in Congestive Heart Failure 2010.
36. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Experimental biology and medicine 2008; 233(6):674-688.
37.Gonzalez R, Ballester I, López-Posadas R, Suárez  MD, Zarzuelo A,  Martinez-Augustin O et al.. Effects of flavonoids and other polyphenols on inflammation. Critical reviews in food science and nutrition 2011;51(4): 331-362.
38.Jäger AK, Saaby  L.  Flavonoids and the CNS. Molecules  2011; 16(2):1471-1485.
39.Favero G, Franceschetti L, Bonomini F, Rodella LF, Rezzani R. Melatonin as an anti-inflammatory agent modulating inflammasome activation. International journal of endocrinology 2017.‏
40.Kaltschmidt B, Kaltschmidt C. NF-KappaB in long-term memory and structural plasticity in the adult mammalian brain. Frontiers in molecular neuroscience 2015; 8: 69.
41.Novío S, Núñez MJ, Amigo G, Freire‐Garabal M. Effects of fluoxetine on the oxidative status of peripheral blood leucocytes of restraint‐stressed mice. Basic & clinical pharmacology & toxicology 2011; 109(5): 365-371.
 
 
Personalized and Precision Medicine Journal
Volume 10, Issue 37 - Serial Number 37
Original article
Spring 2025
Pages 1-8

  • Receive Date 09 February 2025
  • Revise Date 20 April 2024
  • Accept Date 01 June 2025

Home

Publication Ethics

Guide for Authors

Submit Manuscript

Contact Us